ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Climate Change

Takeda teams with GSK, other drugmakers to help cut supplier emissions

Over 1,000 vendors show interest in common system to estimate greenhouse gases

Inside a Pfizer factory in Puurs, Belgium. The pharmaceutical majors' assessment regime will use sensors to collect data on the amount of electricity, water consumption and waste volume at suppliers' factories.   © Reuters

TOKYO -- Japan's Takeda Pharmaceutical, America's Pfizer, British-Swedish multinational AstraZeneca and seven other big drugmakers plan to jointly support reducing the greenhouse gas emissions of their suppliers in an attempt to join the global trend toward decarbonization, Nikkei has learned.

U.K.-based GSK, the U.S.'s Johnson & Johnson and Swiss giant Novartis will also participate.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more